The EPS projection of Itron, Inc. (NASDAQ:ITRI) for quarter ended 2016-09-30 is $0.63. Last week, the projection for EPS was $0.63 against target of $0.63, a month earlier. While 2-months ago, this projection was $0.63 versus forecast of $0.63a quarter months earlier, posting a deviation of 0.03%.
Itron, Inc. (NASDAQ:ITRI) posted that 18 days earlier, the share price was revised 0 times on upside. In addition, negative revisions were 0.
In last week, negative EPS revisions were 0 times and positive EPS revisions were 0 times. In last one-month and two month the positive revisions were 0 and 0. While in last 120 and 90 days, positive revisions were 0, and 0, correspondingly.
The per-share earnings downgrade for Itron, Inc. (NASDAQ:ITRI) in the preceding 30 and 120 were 0 and 0. While in 60 and 90 days were 0, and 0, in that order.
Itron, Inc. (NASDAQ:ITRI) EPS target was $0.63 for the quarter closed 4. It was based on 6 calls. As on 2016-02-17 the EPS was $0.77. The change was $0.05, posting a deviation of 6.94%. The price projections gave a standard deviation of 0.08.
Quarterly Sales Estimates
Itron, Inc. (NASDAQ:ITRI) sales prediction for the fiscal 2016 stands at $499.4 and the median estimate is at $499.4. Almost 2 analysts gave sales target.
Among this, the highest sales estimate is $500 while the lowest target is $498.8 showing standard deviation of 0.848%.
As many as 2 analysts have positive sales targets revision while 2 reduced sales estimates, posting a deviation of 0.624%.
Last month, 2 experts have positive sales number revision. Also, 2 research groups lowered the sales projections, posting a deviation of -1.05%.
A quarter ago, 2 hiked sales target and 2 reduced sales forecast, posting a deviation of -1.57%.
1 Chart Pattern Every Investor Should Know
This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...